Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections
Phase 1
Terminated
- Conditions
- Allergic ConjunctivitisAllergic Rhinitis
- First Posted Date
- 2017-02-01
- Last Posted Date
- 2018-02-26
- Lead Sponsor
- Woodmont Pharmaceuticals, Inc.
- Target Recruit Count
- 2
- Registration Number
- NCT03038971
- Locations
- 🇺🇸
Andover Eye Associates, Andover, Massachusetts, United States
News
No news found